SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Koninklijke Philips N.V. of Class Action Lawsuit and Upcoming Deadline - PHG

NEW YORK, Aug. 27, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Koninklijke Philips N.V. ("Philips" or the "Company") (NYSE: PHG) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-04606, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Philips securities between February 25, 2020 and June 11, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased or otherwise acquired Philips's securities during the Class Period, you have until October 15, 2021 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980.  Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here for information about joining the class action]

Philips operates as a health technology company in North America, Greater China, and internationally.  The Company's products include, among others, Bi-Level Positive Airway Pressure ("Bi-Level PAP") and Continuous Positive Airway Pressure ("CPAP") devices, as well as mechanical ventilators.  Bi-Level PAP machines pump air under pressure into the airway of the lungs.  Bi-Level PAP machines have a higher pressure when users breathe in and lower pressure when users breathe out.  CPAP machines keep users' airway open by providing a continuous stream of air through a mask.  CPAP machines are devices prescribed to people with obstructive sleep apnea to keep their airways open during sleep.  Bi-Level PAP and CPAP machines use Polyester-based polyurethane, a sound abatement foam, to reduce sound and vibration.

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Philips had deficient product manufacturing controls or procedures; (ii) as a result, the Company's Bi-Level PAP and CPAP devices and mechanical ventilators were manufactured using hazardous materials; (iii) accordingly, the Company's sales revenues from the foregoing products were unsustainable; (iv) the foregoing also subjected the Company to a substantial risk of a product recall, in addition to potential legal and/or regulatory action; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

On June 14, 2021, Philips issued a voluntary recall of certain of its Bi-Level PAP and CPAP devices, as well as mechanical ventilators, after finding that the sound abatement foam used in the devices can degrade and become toxic, potentially causing cancer.

On this news, Philips' stock price fell $2.25 per share, or 3.98%, to close at $54.25 per share on June 14, 2021.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980

SOURCE Pomerantz LLP

Related Links

www.pomerantzlaw.com